Difficulty: Medium
Average Score: 85%
Practice
Allopurinol is indicated in the following category of chronic gout patients
Correct answer
D
Rationale
Allopurinol is a xanthine oxidase inhibitor used in the treatment of chronic gout. The correct answer is D) All of the above. This is because allopurinol is indicated for chronic gout patients who fall under all three categories mentioned in the options.
A) Overproducers of uric acid: Allopurinol is effective in patients who overproduce uric acid due to its mechanism of action in inhibiting xanthine oxidase, an enzyme involved in the production of uric acid. By reducing uric acid levels, allopurinol helps prevent gout attacks in these patients.
B) Underexcretors of uric acid: Allopurinol is also beneficial for patients who have impaired excretion of uric acid. By lowering uric acid production, allopurinol can help these patients maintain uric acid levels within the normal range and prevent the formation of urate crystals.
C) Those with tophi and/or renal urate stones: Allopurinol is recommended for patients with tophi (deposits of uric acid crystals in tissues) and/or renal urate stones. By lowering uric acid levels, allopurinol can help dissolve tophi and prevent the formation of new urate stones, thereby improving the management of gout in these patients.
Educational Context: Understanding the appropriate use of allopurinol in different categories of chronic gout patients is essential for healthcare professionals, especially nurses and pharmacists, who play a crucial role in managing gout and educating patients about their medications. By grasping the rationale behind the selection of allopurinol for specific patient groups, healthcare providers can optimize treatment outcomes and improve patient quality of life.
A) Overproducers of uric acid: Allopurinol is effective in patients who overproduce uric acid due to its mechanism of action in inhibiting xanthine oxidase, an enzyme involved in the production of uric acid. By reducing uric acid levels, allopurinol helps prevent gout attacks in these patients.
B) Underexcretors of uric acid: Allopurinol is also beneficial for patients who have impaired excretion of uric acid. By lowering uric acid production, allopurinol can help these patients maintain uric acid levels within the normal range and prevent the formation of urate crystals.
C) Those with tophi and/or renal urate stones: Allopurinol is recommended for patients with tophi (deposits of uric acid crystals in tissues) and/or renal urate stones. By lowering uric acid levels, allopurinol can help dissolve tophi and prevent the formation of new urate stones, thereby improving the management of gout in these patients.
Educational Context: Understanding the appropriate use of allopurinol in different categories of chronic gout patients is essential for healthcare professionals, especially nurses and pharmacists, who play a crucial role in managing gout and educating patients about their medications. By grasping the rationale behind the selection of allopurinol for specific patient groups, healthcare providers can optimize treatment outcomes and improve patient quality of life.